Evaluation of CGRP Levels in Patients With Rosacea: A Prospective Case–Control Study
Dermatologic Therapy · 2026-01 · 2026 (1)
DOI: 10.1155/dth/3024577 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatologic Therapy, online erschienen am 27.06.2026. Verfasst von Esranur Ünal und 5 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Türkiye Bilimsel ve Teknolojik Araştirma Kurumu.
Abstract (Originalsprache)
Introduction
Calcitonin gene–related peptide (CGRP) is a vasoactive neuropeptide implicated in the neurovascular dysregulation and neurogenic inflammation involved in rosacea pathogenesis. However, evidence regarding circulating CGRP levels in rosacea remains limited. Therefore, this study aimed to compare serum CGRP levels between patients with rosacea and healthy controls and to investigate their associations with rosacea severity, subtype, and Demodex positivity.
Methods
Fifty‐five patients with rosacea and 55 age‐ and sex‐matched healthy controls were included in the study. Peripheral blood samples were analyzed for serum CGRP levels using enzyme‐linked immunosorbent assay (ELISA). Disease severity was evaluated using the Rosacea Area and Severity Index (RASI). Demodex density was assessed using the standardized skin surface biopsy technique, and group comparisons were performed.
Results
Serum CGRP levels were significantly lower in patients with rosacea than in healthy controls (4.66 [IQR: 2.93–11.7] vs. 11.1 [IQR: 7.14–79.4] pg/mL, p < 0.001). No significant differences in serum CGRP levels were observed according to rosacea subtype, disease severity, or Demodex positivity ( p > 0.05 for all). In addition, serum CGRP levels did not correlate with RASI scores, Demodex density, or disease duration ( p > 0.05 for all).
Conclusion
The findings suggest that circulating serum CGRP levels may not adequately reflect local cutaneous neurogenic and neurovascular activity in rosacea. The lack of association between serum CGRP levels and clinical severity, rosacea subtype, or Demodex positivity further supports the possibility that local cutaneous CGRP dysregulation may be more relevant than systemic circulating levels in rosacea pathogenesis. Further studies integrating both serum and tissue‐level analyses are needed to clarify the role of CGRP in rosacea pathogenesis.
Förderung
- Türkiye Bilimsel ve Teknolojik Araştirma Kurumu
Zitieren
APA
Ünal, E., Duru, V., Emre, S., Yücel, M. B., Erdoğan, S., & Özdemir, S. Ö. (2026). Evaluation of CGRP Levels in Patients With Rosacea: A Prospective Case–Control Study. Dermatologic Therapy, 2026(1). https://doi.org/10.1155/dth/3024577
Vancouver
Ünal E, Duru V, Emre S, Yücel MB, Erdoğan S, Özdemir SÖ. Evaluation of CGRP Levels in Patients With Rosacea: A Prospective Case–Control Study. Dermatologic Therapy. 2026;2026(1). doi:10.1155/dth/3024577
BibTeX
@article{nal2026,
author = {Ünal, Esranur and Duru, Veysel and Emre, Selma and Yücel, Muhammed Burak and Erdoğan, Serpil and Özdemir, Sinem Örnek},
title = {Evaluation of CGRP Levels in Patients With Rosacea: A Prospective Case–Control Study},
journal = {Dermatologic Therapy},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/dth/3024577}
}
EUVIMED